Neuroadaptive mechanisms of addiction: studies on the extended amygdala

A conceptual structure for drug addiction focused on allostatic changes in reward function that lead to excessive drug intake provides a heuristic framework with which to identify the neurobiologic neuroadaptive mechanisms involved in the development of drug addiction. The brain reward system implicated in the development of addiction is comprised of key elements of a basal forebrain macrostructure termed the extended amygdala and its connections. Neuropharmacologic studies in animal models of addiction have provided evidence for the dysregulation of specific neurochemical mechanisms not only in specific brain reward circuits (opioid peptides, gamma-aminobutyric acid, glutamate and dopamine) but also recruitment of brain stress systems (corticotropin-releasing factor) that provide the negative motivational state that drives addiction, and also are localized in the extended amygdala. The changes in the reward and stress systems are hypothesized to maintain hedonic stability in an allostatic state, as opposed to a homeostatic state, and as such convey the vulnerability for development of dependence and relapse in addiction.

[1]  G. Koob.  Drugs of abuse: anatomy, pharmacology and function of reward pathways. , 1992, Trends in pharmacological sciences.

[2]  G. Koob,et al.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal , 1993, Brain Research.

[3]  G. Edwards.  Drugs and drug dependence , 1976 .

[4]  Decreased brain reward produced by ethanol withdrawal. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Koob,et al.  Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. , 2002, Alcoholism, clinical and experimental research.

[6]  G. Koob,et al.  GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. , 1995, European journal of pharmacology.

[7]  W. Vale,et al.  Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). , 1984, The Journal of pharmacology and experimental therapeutics.

[8]  R. Solomon,et al.  An Opponent-Process Theory of Motivation , 1978 .

[9]  C. Hodge,et al.  Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake , 2002, Pharmacology Biochemistry and Behavior.

[10]  Hong-wei Dong,et al.  Topography of projections from amygdala to bed nuclei of the stria terminalis , 2001, Brain Research Reviews.

[11]  C. Heyser,et al.  Central administration of an opiate antagonist decreases oral ethanol self-administration in rats. , 1999, Alcoholism, clinical and experimental research.

[12]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[13]  R. Spealman,et al.  Antagonism of cocaine self‐administration by selective dopamine D1 and D2 antagonists , 1990, Behavioural pharmacology.

[14]  Michael Davis,et al.  Cortical Afferents to the Extended Amygdala , 1999, Annals of the New York Academy of Sciences.

[15]  G. Alheid.  Amygdala and extended amygdala , 1995 .

[16]  E. Gardner,et al.  Cannabinoid Transmission and Reward-Related Events , 1998, Neurobiology of Disease.

[17]  G. F. Koob,et al.  Pretreatment with the dopamine agonist 7‐OH‐DPAT shifts the cocaine self‐administration dose‐effect function to the left under different schedules in the rat , 1995, Behavioural pharmacology.

[18]  T. Kozicz.  Axon terminals containing tyrosine hydroxylase- and dopamine-β-hydroxylase immunoreactivity form synapses with galanin immunoreactive neurons in the lateral division of the bed nucleus of the stria terminalis in the rat , 2001, Brain Research.

[19]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[20]  C. Wilkinson,et al.  Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. , 2000, Alcoholism, clinical and experimental research.

[21]  C. Phelix,et al.  Demonstration of distinct corticotropin releasing factor — containing neuron populations in the bed nucleus of the stria terminalis. A light and electron microscopic immunocytochemical study in the rat , 2004, Histochemistry.

[22]  G F Koob,et al.  Postcocaine anhedonia: An animal model of cocaine withdrawal and its reversal by pharmacological treatments Athina Markou, M.A., Richard L. Hauger, M.D., George F. Koob, Ph.D. Department of Neuropharmacology, Research Institute of Scripps Clinic, La Jolla, CA 92037 , 1991, Biological Psychiatry.

[23]  G. Koob,et al.  Suppression of corticotropin‐releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal , 1995, Behavioural pharmacology.

[24]  G. Koob,et al.  Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  M. Martres,et al.  Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain , 1995, Neuroscience.

[26]  F. Bloom,et al.  Neuroscience of Addiction , 1998, Neuron.

[27]  A. Markou,et al.  Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats , 2000, Psychopharmacology.

[28]  G. Koob,et al.  Opiate Withdrawal-Induced Fos Immunoreactivity in the Rat Extended Amygdala Parallels the Development of Conditioned Place Aversion , 2001, Neuropsychopharmacology.

[29]  G. Aston-Jones,et al.  Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion , 2000, Nature.

[30]  G. Koob,et al.  Drug Addiction, Dysregulation of Reward, and Allostasis , 2001, Neuropsychopharmacology.

[31]  G. Koob,et al.  Corticotropin releasing factor, stress and behavior , 1994 .

[32]  G. Koob,et al.  Dramatic decreases in brain reward function during nicotine withdrawal , 1998, Nature.

[33]  G. Paxinos.  The Rat nervous system , 1985 .

[34]  C. Heyser,et al.  Substance dependence as a compulsive behavior , 1998, Journal of psychopharmacology.

[35]  T. Gray,et al.  Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat , 1992, Peptides.

[36]  G. Koob,et al.  Alcoholism: allostasis and beyond. , 2003, Alcoholism, clinical and experimental research.

[37]  A. Johns.  What is Dependence , 1990 .

[38]  L. Heimer,et al.  Piecing together the puzzle of basal forebrain anatomy. , 1991, Advances in experimental medicine and biology.

[39]  G. Koob.  Hedonic valence, dopamine and motivation. , 1996, Molecular psychiatry.

[40]  T. Crow,et al.  Neuropeptide Y in the stria terminalis: evidence for an amygdalofugal projection , 1984, Brain Research.

[41]  G. Koob,et al.  Opponent process and drug dependence: Neurobiological mechanisms , 1993 .

[42]  G Schulteis,et al.  Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. , 1994, The Journal of pharmacology and experimental therapeutics.

[43]  G. Koob,et al.  The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat , 1998, Brain Research.

[44]  F Weiss,et al.  In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self‐administering rats , 1999, Synapse.

[45]  G F Koob,et al.  Drug abuse: hedonic homeostatic dysregulation. , 1997, Science.

[46]  S. B. Caine,et al.  Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat , 1995, Brain Research.

[47]  G. Di Chiara,et al.  Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. Koob,et al.  Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. , 1996, Alcoholism, clinical and experimental research.